COMT Val carriers (both Val-Val and Val-Met) are considered relatively at risk for specific cognitive deficits with aging (e.g., Barnett et al., 2008; Wishart et al., 2011) and possibly MCI (Martinez et al., 2009; Lanni et al., 2012). The gene discussed is COMT; the disease is Cognitive impairment.